Ateş İhsan, Altay Mustafa, Topçuoğlu Canan, Yılmaz Fatma Meriç
Department of Internal Medicine, Ankara Numune Education and Research Hospital, Ankara, Turkey.
Department of Biochemistry, Ankara Numune Education and Research Hospital, Ankara, Turkey.
Arch Endocrinol Metab. 2016 Apr;60(2):95-100. doi: 10.1590/2359-3997000000077. Epub 2015 Jul 21.
Objective Our objective in this study was to determine the relationship between irisin hormone, which has a similar effect with thyroid hormones on adipose tissue and the metabolism, and the thyroid functions and the obesity secondary to thyroid disease. Subjects and methods Seventy-four patients were included in the study, of the patients, 37 were newly diagnosed with Hashimoto's thyroiditis related hypothyroidism but not started on a treatment yet, and the remaining 37 were healthy volunteers without a known disease. Serum thyroid stimulating hormone (TSH), free thyroxin (fT4), anti-thyroglobulin and anti-thyroid peroxidase were measured and thyroid ultrasonography was performed in both groups. Serum irisin levels were measured using the commercially available ELISA kit. The hypothyroidism group had higher levels of irisin compared to the control group (2.77 ng/mL vs. 2.15 ng/mL respectively; p = 0.017). Results The hypothyroidism group had higher median levels of irisin in the obese patients than those in the control group (3.10 ng/mL vs. 2.10 ng/mL respectively; p = 0.013). Irisin level was negatively correlated with age in the whole population and patients with hypothyroidism (r = -0.255, p = 0.028; r = -0.346, p = 0.036 respectively). Irisin level was positively correlated with TSH (r = 0.247, p = 0.034) but negatively correlated with the fT4 (r = -0.316, p = 0.006) in the whole population. Obesity, fT4 and irisin levels were identified to be independent predictors in the diagnosis of hypothyroidism in the multivariable logistic regression analysis. Conclusion To the best of our knowledge, this study is the first in literature to identify that obesity, irisin level and fT4 level are independent risk factors for hypothyroidism.
目的 本研究的目的是确定鸢尾素激素(其在脂肪组织和代谢方面具有与甲状腺激素相似的作用)与甲状腺功能以及甲状腺疾病继发的肥胖之间的关系。
受试者与方法 本研究纳入了74例患者,其中37例为新诊断的桥本甲状腺炎相关性甲状腺功能减退症患者,但尚未开始治疗,其余37例为无已知疾病的健康志愿者。两组均检测了血清促甲状腺激素(TSH)、游离甲状腺素(fT4)、抗甲状腺球蛋白和抗甲状腺过氧化物酶,并进行了甲状腺超声检查。使用市售酶联免疫吸附测定(ELISA)试剂盒检测血清鸢尾素水平。甲状腺功能减退症组的鸢尾素水平高于对照组(分别为2.77 ng/mL和2.15 ng/mL;p = 0.017)。
结果 肥胖的甲状腺功能减退症患者的鸢尾素中位数水平高于对照组(分别为3.10 ng/mL和2.